Latest Articles

Publication Date
Functional Impairment of Activated Regulatory T Cells as a Central Immunological Defect in Endometriosis.

Endometriosis is increasingly recognized as a disorder of impaired reproductive immune tolerance rather than solely an endocrine disease. Although previous studies have reported inconsistent findings regarding the number of regulatory …

Published: April 16, 2026, midnight
Metabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis [Response to Letter].

Published: April 16, 2026, midnight
Diagnosis and management of endometriosis-associated infertility Number 4 - 2026.

Published: April 16, 2026, midnight
Medical and Surgical Management of Endometriosis: A Narrative Review of Clinical Outcomes.

Endometriosis is a chronic, estrogen-dependent, and heterogeneous gynecologic disorder associated with persistent pain, infertility, and substantial impairment in quality of life (QoL), necessitating individualized and evidence-based management. This narrative review …

Published: April 16, 2026, midnight
Lena Dunham Famesick: An Unflinching Memoir - Chatelaine

Lena Dunham Famesick: An Unflinching Memoir Chatelaine

Published: April 15, 2026, 6:30 p.m.
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma - Oncology Nursing News

Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma Oncology Nursing News

Published: April 15, 2026, 4:59 p.m.
Herbal health supplement sold nationwide recalled over deadly botulism risk - newscentermaine.com

Herbal health supplement sold nationwide recalled over deadly botulism risk newscentermaine.com

Published: April 15, 2026, 3:44 p.m.
Naga Munchetty opens up about extremely painful health condition that took doctors years to diagnose - AOL.com

Naga Munchetty opens up about extremely painful health condition that took doctors years to diagnose AOL.com

Published: April 15, 2026, 11:54 a.m.
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression - The Manila Times

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression The Manila Times

Published: April 15, 2026, 11:45 a.m.
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression - GlobeNewswire

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression GlobeNewswire

Published: April 15, 2026, 11:30 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!